Development and Validation of a Simultaneous HPLC Method for Quantification of Atenolol and Amlodipine Besylate in Tablet Form
DOI:
https://doi.org/10.32628/IJSRST2613158Keywords:
Atenolol and Amlodipine Besylate Method development Validation, High performance liquid chromatography, quantificationAbstract
A Reverse phase method has been developed for the quantitative estimation of Atenolol and Amlodipine Besylate in Tablets. The Quantification was carried out using RP stainless steel column ODS C18 250 x 4.6 x 5 μ L1 packing in Isocratic mode with mobile phase containing 0.03 M potassium buffer: Acetonitrile in the ratio of 50:50 Adjust pH3.5 with ortho-phosphoric acid. Degas this solution before use. Flow rate 1.0 ml/minute and the detection wavelength was set at 237 nm and the linearity was found to be in the range of 16-22 ug/ml for Atenolol and 8 to 12 ug/ml for Amlodipine Besylate. The proposed method was found to be simple, precise, accurate, reproducible for the Estimation of Atenolol and Amlodipine Besylate.
Downloads
References
ICH-Q2B Validation of Analytical procedure: Methodology International Conference on Harmonization of Technical Requirement for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland,1996.
ICH,Q2A validation of analytical procedure, Methodology International Conference on Harmonization, Geneva, October 1994.
US FDA. Guideline for industry: text on validation of analytical procedures: ICH Q2A.Rockville, MD:Mar 1995.
GLP-The United Kingdom Compliance Programme (Department of Health) 1989.
Code of Federal Regulation 21 part 21 J.160 (Government Printing office Washington DC (1978.)
BS 7501 EN 45001. General Criteria for the operation of Testing Laboratories 1989.
United state Pharmacopia XXI United State Pharmacopeial Convention Rockvile,MD,1990.
Validation of Analytical procedure, Methodology, ICH Harmonzed tripartite guidelines, 1996;1-8
RP-HPLC -Atenolol, Hydrochlorothiazide and losartan. A. Thomas, U. Chavan, R Nanda,L.Kothapally, S. Uagdale, S. Dhigle, S. Despande, Acta chromatographica,2010;22 (2): 219-226. DOI: https://doi.org/10.1556/AChrom.22.2010.2.5
Atenolol and Verapamil. A.Bright T.S.Renuga Devi,S. Gunashekharan Int. Jour of chem. Tech research, 2010;2(2).
G.AI.A: An Integrated Machine-Learning Platform for Predicting Bioaccumulation and Ecotoxicity of Pharmaceuticals. By: Tsoukas, Evangelos; Papadourakis, Michail; Chontzopoulou, Eleni; Vythoulkas, Spyridon; Didachos, Christos; Cavouras, Dionisis; Zoumpoulakis, Panagiotis; Matsoukas, Minos-Timotheos Journal of Chemical Information and Modeling (2026), 66(3), 1414-1428. DOI: https://doi.org/10.1021/acs.jcim.5c02286
A High-resolution dataset for AI-driven segmentation and analysis of drug-treated breast tumor spheroids By: Tahmasbi, Amir; Ahvaraki, Akram; Behroodi, Ebrahim; Ghaffari, Aboozar; Bagheri, Zeinab; Vakhshiteh, Faezeh; Latifi, Hamid; Madjd, Zahra. Computer methods and programs in biomedicine (2026), 274, 109141. DOI: https://doi.org/10.1016/j.cmpb.2025.109141
Preclinical development of mesothelin-targeting CAR T cells for the treatment of cholangiocarcinoma. By: Duangdara, Jinchutha; Lin, Shaoli; Hong, Jessica; Li, Dan; Suriyonplengsaeng, Chinnawut; Larbcharoensub, Noppadol;Wongprasert,Kanokpan;Ho,Mitchell.Hepatology communications (2026), 10(2). DOI: https://doi.org/10.1097/HC9.0000000000000888
Accelerating Discovery of Leukemia Inhibitors Using AI-Driven Quantitative Structure-Activity Relationship: Algorithm Development and Validation. By: Kakraba, Samuel; Agyemang, Edmund Fosu; Shmookler Reis, Robert J. JMIR AI (2026), 5, e81552. DOI: https://doi.org/10.2196/81552
Indian Pharmacopoeia Reference Standards: A Key Tool to Regulate the Quality of Pharmaceuticals. By: Sharma, Arvind Kumar; Rastogi, Shruti; Nagar, Priyanka; Tiwari, Suraj; Yadav, Anuj Prakash; Kumar, Robin; Kalaiselvan, Vivekanandan. Therapeutic innovation & regulatory science (2026). DOI: https://doi.org/10.1007/s43441-026-00916-0
Quantification of buparlisib in human liver microsomes employing an ultra-fast, sensitive UPLC-MS/MS method: in vitro and in silico metabolic stability evaluation. By: Attwa, Mohamed W; AlRabiah, Haitham; Abdelhameed, Ali S; Kadi, Adnan A. The Analyst (2026).
Exploiting Unsupervised Free-Living Data for Cardiorespiratory Fitness Estimation: Systematic Review and Meta-Analysis. By: Dosis, Alexios; Syversen, Aron Berger; Kowal, Mikolaj R; Grant, Daniel; Tiernan, Jim; Wong, David; Jayne, David G. JMIR mHealth and uHealth (2026), 14, e69996. DOI: https://doi.org/10.2196/69996
RUBCN as a novel prognostic biomarker and therapeutic target in breast cancer. By: Yang, Dong Dong; Liu, Cheng Hao; Jia, Sheng Qiu; Xue, Ze Kuan; Zhang, Ming Ming; Yang, Rui; Huang, Yong Zhou; Zhao, Xin Chun; Han, Bao San; Nie, Sheng Dong; et al. PloS one (2026), 21(1), e0341357. DOI: https://doi.org/10.1371/journal.pone.0341357
Targeted paclitaxel delivery in ovarian cancer via AP1-functionalized elastin-like polypeptide nanocarriers: development and characterization. By: Goel, Ridhima; Alvi, Shakeel; Ali, Rashid; Sharma, Pradeep; Bhattacharyya, Jayanta; Sarangthem, Vijaya; Singh, Thoudam Debraj. BMC cancer (2026).
Revealing the Action Mechanism of Exogenous Hydrogen Sulfide Intervention in Colorectal Cancer Pathogenesis Based on Multiomics Analysis and Experimental Validation. By: Cui, Facai; Yu, Chen; Zhao, Weifeng; Shi, Juan; Liu, Yang; Liu, Fengzhen; Nair, SujitHuman mutation (2026), 2026, 5595505. DOI: https://doi.org/10.1155/humu/5595505
Downloads
Published
Issue
Section
License
Copyright (c) 2026 International Journal of Scientific Research in Science and Technology
This work is licensed under a Creative Commons Attribution 4.0 International License.
https://creativecommons.org/licenses/by/4.0
